Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Ventas (VTR)

NYSE: VTR · Health Care REITs · Chicago, IL

Our rating: Positive

Positive reaffirmed at $83.71, moderate conviction, October 29, 2026.

Breaks if: The Positive view breaks down if revenue growth decelerates to below 8% year-over-year in either of the next two quarterly reports — a signal that the senior housing recovery has plateaued and the premium embedded in the current market cap is no longer supported by the trajectory. A drawdown of 20% from the current price within twelve months would suggest the market is re-rating ahead of a fundamental deterioration this thesis does not yet anticipate.

Key figures

Market value$45.8B
Revenue, last 12 months$6.8B
Net income, last 12 months$272M
Free cash flow, last 12 monthsn/a
Price to earnings168.6×
Free cash flow yieldn/a
Dividend yield2.4%
Operating marginn/a
Return on equity1.9%
Beta to the S&P 5000.12
Volatility, annualized21.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.8B23.0%$0.13n/a
June 30, 2026$1.7B21.7%$0.14n/a
March 31, 2026$1.7B22.0%$0.11n/a
December 31, 2025$1.6B21.7%$0.14n/a
September 30, 2025$1.5B20.4%$0.14n/a
June 30, 2025$1.4B18.3%$0.15n/a
March 31, 2025$1.4B13.2%$0.10n/a
December 31, 2024$1.3B10.5%$0.13n/a

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

11 ledger entries and 26 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.